Edwards Lifesciences (EW) Tops Q2 EPS by 5c; Issues Mixed Guidance
Tweet Send to a Friend
Edwards Lifesciences (NYSE: EW) reports Q2 EPS of $0.81, 5 cents better than the analyst estimate of $0.76. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
